Cargando…

Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach

Neurological diseases (NDs), especially Alzheimer’s and Spinocerebellar ataxia (SCA), can severely cause biochemical abnormalities in the brain, spinal cord and other nerves of human beings. Their ever-increasing prevalence has led to a demand for new drug development. Indian traditional and Ayurved...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeyasri, Rajendran, Muthuramalingam, Pandiyan, Suba, Vellaichami, Ramesh, Manikandan, Chen, Jen-Tsung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225932/
https://www.ncbi.nlm.nih.gov/pubmed/32252235
http://dx.doi.org/10.3390/biom10040536
_version_ 1783534168597069824
author Jeyasri, Rajendran
Muthuramalingam, Pandiyan
Suba, Vellaichami
Ramesh, Manikandan
Chen, Jen-Tsung
author_facet Jeyasri, Rajendran
Muthuramalingam, Pandiyan
Suba, Vellaichami
Ramesh, Manikandan
Chen, Jen-Tsung
author_sort Jeyasri, Rajendran
collection PubMed
description Neurological diseases (NDs), especially Alzheimer’s and Spinocerebellar ataxia (SCA), can severely cause biochemical abnormalities in the brain, spinal cord and other nerves of human beings. Their ever-increasing prevalence has led to a demand for new drug development. Indian traditional and Ayurvedic medicine used to combat the complex diseases from a holistic and integrative point of view has shown efficiency and effectiveness in the treatment of NDs. Bacopa monnieri is a potent Indian medicinal herb used for multiple ailments, but is significantly known as a nootropic or brain tonic and memory enhancer. This annual herb has various active compounds and acts as an alternative and complementary medicine in various countries. However, system-level insights of the molecular mechanism of a multiscale treatment strategy for NDs is still a bottleneck. Considering its prominence, we used cheminformatics and system pharmacological approaches, with the aim to unravel the various molecular mechanisms represented by Bacopa-derived compounds in identifying the active human targets when treating NDs. First, using cheminformatics analysis combined with the drug target mining process, 52 active compounds and their corresponding 780 direct receptors were retrieved and computationally validated. Based on the molecular properties, bioactive scores and comparative analysis with commercially available drugs, novel and active compounds such as asiatic acid (ASTA) and loliolide (LLD) to treat the Alzheimer’s and SCA were identified. According to the interactions among the active compounds, the targets and diseases were further analyzed to decipher the deeper pharmacological actions of the drug. NDs consist of complex regulatory modules that are integrated to dissect the therapeutic effects of compounds derived from Bacopa in various pathological features and their encoding biological processes. All these revealed that Bacopa compounds have several curative activities in regulating the various biological processes of NDs and also pave the way for the treatment of various diseases in modern medicine.
format Online
Article
Text
id pubmed-7225932
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72259322020-05-18 Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach Jeyasri, Rajendran Muthuramalingam, Pandiyan Suba, Vellaichami Ramesh, Manikandan Chen, Jen-Tsung Biomolecules Article Neurological diseases (NDs), especially Alzheimer’s and Spinocerebellar ataxia (SCA), can severely cause biochemical abnormalities in the brain, spinal cord and other nerves of human beings. Their ever-increasing prevalence has led to a demand for new drug development. Indian traditional and Ayurvedic medicine used to combat the complex diseases from a holistic and integrative point of view has shown efficiency and effectiveness in the treatment of NDs. Bacopa monnieri is a potent Indian medicinal herb used for multiple ailments, but is significantly known as a nootropic or brain tonic and memory enhancer. This annual herb has various active compounds and acts as an alternative and complementary medicine in various countries. However, system-level insights of the molecular mechanism of a multiscale treatment strategy for NDs is still a bottleneck. Considering its prominence, we used cheminformatics and system pharmacological approaches, with the aim to unravel the various molecular mechanisms represented by Bacopa-derived compounds in identifying the active human targets when treating NDs. First, using cheminformatics analysis combined with the drug target mining process, 52 active compounds and their corresponding 780 direct receptors were retrieved and computationally validated. Based on the molecular properties, bioactive scores and comparative analysis with commercially available drugs, novel and active compounds such as asiatic acid (ASTA) and loliolide (LLD) to treat the Alzheimer’s and SCA were identified. According to the interactions among the active compounds, the targets and diseases were further analyzed to decipher the deeper pharmacological actions of the drug. NDs consist of complex regulatory modules that are integrated to dissect the therapeutic effects of compounds derived from Bacopa in various pathological features and their encoding biological processes. All these revealed that Bacopa compounds have several curative activities in regulating the various biological processes of NDs and also pave the way for the treatment of various diseases in modern medicine. MDPI 2020-04-02 /pmc/articles/PMC7225932/ /pubmed/32252235 http://dx.doi.org/10.3390/biom10040536 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jeyasri, Rajendran
Muthuramalingam, Pandiyan
Suba, Vellaichami
Ramesh, Manikandan
Chen, Jen-Tsung
Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach
title Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach
title_full Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach
title_fullStr Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach
title_full_unstemmed Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach
title_short Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach
title_sort bacopa monnieri and their bioactive compounds inferred multi-target treatment strategy for neurological diseases: a cheminformatics and system pharmacology approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225932/
https://www.ncbi.nlm.nih.gov/pubmed/32252235
http://dx.doi.org/10.3390/biom10040536
work_keys_str_mv AT jeyasrirajendran bacopamonnieriandtheirbioactivecompoundsinferredmultitargettreatmentstrategyforneurologicaldiseasesacheminformaticsandsystempharmacologyapproach
AT muthuramalingampandiyan bacopamonnieriandtheirbioactivecompoundsinferredmultitargettreatmentstrategyforneurologicaldiseasesacheminformaticsandsystempharmacologyapproach
AT subavellaichami bacopamonnieriandtheirbioactivecompoundsinferredmultitargettreatmentstrategyforneurologicaldiseasesacheminformaticsandsystempharmacologyapproach
AT rameshmanikandan bacopamonnieriandtheirbioactivecompoundsinferredmultitargettreatmentstrategyforneurologicaldiseasesacheminformaticsandsystempharmacologyapproach
AT chenjentsung bacopamonnieriandtheirbioactivecompoundsinferredmultitargettreatmentstrategyforneurologicaldiseasesacheminformaticsandsystempharmacologyapproach